Maternal blood serum and plasma human tumor-associated antigen RCAS1 during the course of uncomplicated pregnancies: A prospective study

American Journal of Reproductive Immunology

Volumn 64, Issue 3, 2010, Pages 218-224

  Tskitishvili, Ekaterine ^a   Sharentuya, Namuxila ^a   Tsubouchi, Hiroaki ^a   Kinugasa Taniguchi, Yukiko ^a   Kanagawa, Takeshi ^a   Shimoya, Koichiro ^b   Tomimatsu, Takuji ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Maternal blood; Plasma RCAS1 mRNA; Serum RCAS1; Uncomplicated pregnancy

Indexed keywords

MESSENGER RNA; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN RCAS1; UNCLASSIFIED DRUG;

DELIVERY; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; HUMAN; HUMAN EXPERIMENT; MATERNAL SERUM; NORMAL HUMAN; PH; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; UPREGULATION;

ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; IMMUNE TOLERANCE; PLACENTATION; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 77955639344     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00859.x     Document Type: Editorial

References (27)

1. Sargent IL, Borzychowski AM, Redman C. NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006, 27:399-404.
2. Yagel S. The developmental role of natural killer cells at the fetal-maternal interface. Am J Obstet Gynecol 2009, 201:344-350.
3. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999, 5:938-942.
4. Matsushima M, Nakashima M, Ohshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001, 98:313-321.
5. Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K. The molecular changes during placental detachment. Eur J Obstet Gynecol Reprod Biol 2006, 125:171-175.
6. Reimer TA, Anagnostopoulos I, Erdmann B, Lehmann I, Stein H, Daniel P, Dorken B, Rehm A. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. BMC Cancer 2005, 5:47.
7. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996, 77:1501-1509.
8. Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S. Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem Biophys Res Commun 2000, 273:654-660.
9. Tsuchiya F, Ikeda K, Tsutsumi O, Hiroi H, Momoeda M, Taketani Y, Muratasu M, Inoue S. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen. Biochem Biophys Res Commun 2001, 284:2-10.
10. Akahira JI, Aoki M, Suzuki T, Moriya T, Niikura H, Ito K, Inoue S, Okamura K, Sasano H, Yaegashi N. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br J Cancer 2004, 90:2197-2202.
11. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006, 66:1181-1190.
12. Giaginis C, Giagini A, Theocharis S. Receptor-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and prognosis of human neoplasia. Histol Histopahol 2009, 24:761-776.
13. Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 1999, 5:1449-1453.
14. Sonoda k, Miyamato S, Yamazaki A, Kobayashi H, Nakashima M, Mekada E, Wake N. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human tumor uterine cancer. Cancer 2007, 110:1979-1990.
15. Han Y, Qin W, Huang G. Knockdown of RCAS1 expression by RNA interference recovers T cell growth and proliferation. Caner Lett 2007, 257:182-190.
16. Sonoda K, Miyamoto S, Yotsumoto F, Yagi H, Nakashima M, Watanabe K, Nakano H. Clinical significance of RCAS1 as a biomarker of ovarian cancer. Oncol Rep 2007, 17:623-628.
17. Wicherek L, Dutsch M, Mak P, Klimek M, Skladzien J, Dubin A. Comparative analysis of RCAS1 level in neoplasms and placenta. Acta Biochim Pol 2003, 50:1187-1194.
18. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T. Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin Exp Immunol 2001, 123:481-486.
19. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M. The Role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005, 20:420-425.
20. Wicherek L, Klimek M, Dutsch-Wicherek M. The level of maternal immune tolerance and fetal maturity. Neuro Endocrinol Lett 2005, 26:561-566.
21. Galazka K, Wicherek L, Sikora J, Czekierdowski A, Banas T, Bednarek W, Obrzut B, Blecharz P, Reron A, Kalinka J. RCAs1 decidual immunoreactivity during stillbirth: immune cell presence and activity. Am J Reprod Immunol 2008, 60:513-522.
22. Wicherek L, Klimek M, Czekierdowski A, Popiela TJ, Galazka K, Tetlak T, Gilowski A, Dutsch-Wicherek M. The placental RCAS1 expression during stillbirth. Reprod Biol Endocrinol 2005, 3:24.
23. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K. Relationship between human tumor-associated antigen RCAS1 and gestational diabetes mellitus. Am J Reprod Immunol 2007, 58:440-446.
24. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K. The human tumor-associated antigen RCAS1 in pregnancies complicated by preeclampsia. J Reprod Immunol 2008, 77:100-108.
25. Tskitishvili E, Nakamura H, Kinugasa-Taniguchi Y, Kanagawa T, Kimura T, Tomimatsu T, Shimoya K. Temporal and spatial expression of tumor-associated antigen RCAS1 in pregnant muse uterus. Am J Reprod Immunol 2010, 63:137-143.
26. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, Lit LC, Chan KW, Lo YM. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003, 100:4748-4753.
27. Lo DYM, Chiu RWK. The biology and diagnostic applications of plasma RNA. Ann NY Acad Sci 2004, 1022:135-139.